KYMR R&D Expense Growth

Kymera Therapeutics Inc · R&D Expense Growth

KYMR logo

KYMR R&D Expense Growth

Latest reported31.78%
KYMR FY R&D Growth (YoY) (0.00% → 31.78%)
High-resolution chart · PNG

KYMR r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
31.7805%
27.0609%
15.1192%
19.8742%
120.6215%
67.1376%
110.1816%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.